fluorodeoxyglucose f18 has been researched along with Adenocarcinoma Of Kidney in 208 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (0.48) | 18.7374 |
| 1990's | 5 (2.40) | 18.2507 |
| 2000's | 47 (22.60) | 29.6817 |
| 2010's | 104 (50.00) | 24.3611 |
| 2020's | 51 (24.52) | 2.80 |
| Authors | Studies |
|---|---|
| Gulturk, I; Tacar, SY; Tural, D; Yilmaz, M | 1 |
| Dunglison, N; Esler, R; Kwok, M; Kyle, S; Marsh, P; McBean, R; Navaratnam, A; Pattison, DA; Pearce, A; Raveenthiran, S; Rhee, H; Roberts, MJ; Tariq, A; Thomas, P; Westera, J; Wong, D; Yaxley, JW | 1 |
| Agrawal, A; Purandare, N; Puranik, A; Rangarajan, V; Shah, S; Suthar, RR | 1 |
| Fan, Y; Shen, Q; Sun, H; Tong, Z; Zhang, J | 1 |
| Du, B; Li, X; Li, Y; Wang, S | 1 |
| Hu, S; Ni, J; Xu, H; Yin, Q; Zhong, Y | 1 |
| Alçin, G; Beyhan, E; Çermik, TF; Erol Fenercioglu, Ö; Şengül Samanci, N; Tatar, G | 1 |
| Liu, Y; Tong, G; Wen, Z | 1 |
| Das, CK; Goyal, H; Kumar, R; Sekar, A; Singh, H; T, T | 1 |
| Baloğlu, MC; Çermik, TF; Ergül, N; Erol Fenercioğlu, Ö; Yahşi, S | 1 |
| Dong, A; Wang, Y; Zhang, J | 1 |
| Dong, A; Yu, Z; Zhang, J; Zhu, Y | 1 |
| Cheng, C; Dong, A; Hua, M; Yang, Q; Zuo, C | 1 |
| Berti, S; El Khouzai, B; Gregianin, M; Guglielmo, P; Muccioli, S; Pesella, F; Sartorello, A | 1 |
| Dong, A; Yang, J; Zuo, C | 1 |
| Koyasu, S; Matsunaga, M; Nakamoto, Y; Sugimoto, A; Tsukamoto, S | 1 |
| Pereira, M; Punatar, CB; Sagade, SN; Singh, N | 1 |
| Fu, L; Xie, F; Zhou, W | 1 |
| Bartel, T; Darr, C; Fendler, WP; Ferdinandus, J; Grünwald, V; Kesch, C; Maríc, I | 1 |
| Aarntzen, EHJG; Angus, L; Arens, AIJ; Brouwers, AH; Desar, IME; Eisses, B; Elias, SG; Gerritse, SL; Heskamp, S; Hoekstra, OS; Menke-van der Houven van Oordt, CW; Mulders, PFA; Oosting, SF; Oyen, WJG; van der Graaf, WTA; van der Veldt, AAM; van Es, SC; van Herpen, CML; Verhoeff, SR; Zwezerijnen, GJC | 1 |
| Arikan, R; Basoglu, T; Bayoglu, V; Celebi, A; Dane, F; Demircan, NC; Ercelep, O; Erdil, TY; Filizoglu, N; Isik, S; Kostek, O; Ones, T; Ozguven, S; Ozturk, MA; Telli, TA; Tinay, I; Turoglu, HT; Ustun, HS; Yasar, A; Yumuk, PF | 1 |
| Belho, ES; Dey, S; Drolia, B; Gupta, N; Jain, S; Sunil, GS; Verma, R | 1 |
| Civan, C; Isik, EG; Karadogan, S; Kuyumcu, S; Sanli, Y | 1 |
| Bai, Y; Dong, A; Yang, B; Zuo, C | 1 |
| Hou, G; Zhang, W; Zheng, R | 1 |
| Dong, K; Dong, M; Fu, J; Guanghua, W; Jiang, T; Li, C; Zheng, H; Zhou, S | 1 |
| Barwad, A; Batra, A; Hemrom, A; Jha, S; Shamim, SA | 1 |
| Chen, X; Guo, Z; Jakobsson, V; Lin, R; Miao, W; Wang, C; Wen, X; Wu, X; Yang, Y; Zang, J; Zhang, J; Zhao, T | 1 |
| Lin, R; Miao, W; Wang, C; Xu, F; Zang, J | 1 |
| Fleury, AS; Zhuang, H | 1 |
| Eluvathingal, TJ; Jain, AL; Karivedu, V; Sidana, A | 1 |
| Cheng, Z; Yao, Y; Zuo, Z | 1 |
| Carlomagno, N; Galatola, R; Guadagno, E; Insabato, L; Mainolfi, C; Maurea, S; Santangelo, M; Sirignano, C; Stanzione, A | 1 |
| Carella, C; Ferrari, C; Naglieri, E; Nappi, AG; Niccoli Asabella, A; Rubini, G | 1 |
| Asghar, N; Hassan, A | 1 |
| Agrawal, A; Bakshi, G; M V, M; Menon, S; Prakash, G; Purandare, N; Puranik, A; Rangarajan, V; Shah, S | 1 |
| Arora, G; Jana, S; Kumar, R; Kumari, K; Nayak, B; Pandey, AK; Patel, C; Seth, A; Sharma, A; Singh, G; Singh, H | 1 |
| Chen, EJ; Chew, MT; Chye, PC; Tan, TH | 1 |
| Artigas, C; Flamen, P; Gil, T; Lemort, M; Mestrez, F | 1 |
| Dong, J; Ji, Z; Xu, W | 1 |
| Gao, J; Lin, M; Liu, Y; Wang, G; Wu, Y; Xu, B; Yu, H | 1 |
| Ambrogi, C; Bagni, O; Filippi, L; Iannarelli, A | 1 |
| Amano, Y; Omori, Y; Takagi, R; Tang, X; Yanagisawa, F | 1 |
| Cheng, W; Hou, G; Huo, L; Jiang, Y; Li, F; Zhao, D; Zhu, Z | 1 |
| Ahlman, MA; Ball, MW; Civelek, AC; Farhadi, F; Jones, EC; Li, X; Linehan, WM; Malayeri, AA; Merino, MJ; Mirmomen, SM; Nikpanah, M; Paschall, AK; Saboury, B; Srinivasan, R | 1 |
| Civan, C; Erdem, S; Has Simsek, D; Sanli, Y | 1 |
| Cao, J; Yang, Y | 1 |
| Lee, HY; Lee, S; Park, S | 1 |
| Fu, C; Li, D; You, Y; Zhang, Q; Zhang, X | 1 |
| Baldari, G; Gasparro, D; Guglielmo, P; Maestroni, U; Manuguerra, R; Migliari, S; Ruffini, L; Sammartano, A; Scarlattei, M; Silini, EM | 1 |
| Fu, P; Han, W; Jiang, H; Wang, M; Zhang, L; Zhao, H | 1 |
| Hasumi, H; Hattori, Y; Hayashi, N; Inoue, T; Ito, H; Kaneta, T; Kawahara, T; Kobayashi, K; Kondo, K; Makiyama, K; Miyoshi, Y; Nakaigawa, N; Namura, K; Osaka, K; Tateishi, U; Teranishi, JI; Uemura, H; Ueno, D; Yao, M; Yokomizo, Y; Yumura, Y | 1 |
| Meijerink, MR; Melenhorst, MCAM; Scheffer, HJ; van den Tol, MP; van Grieken, N; Vroomen, LGPH | 1 |
| Abe, K; Kondo, T; Nagashima, Y; Nakajima, R; Nozaki, S; Sakai, S | 1 |
| Cook, G; Goh, V; Kelly-Morland, C; Mallett, S; Montana, G; Nathan, P; Rudman, S | 1 |
| Dias, F; Medeiros, R; Morais, M; Teixeira, AL | 1 |
| Chiba, S; Hattori, Y; Kawahara, T; Miyoshi, Y; Mochizuki, T; Shimokihara, K; Takamoto, D; Teranishi, JI; Uemura, H | 1 |
| Fujimoto, J; Fukushima, K; Hatano, E; Hirota, S; Kanematsu, A; Kato, T; Kihara, T; Kitajima, K; Kobayashi, K; Nakanishi, Y; Nakasho, K; Nojima, M; Odawara, S; Suzumura, K; Takaki, H; Yamakado, K; Yamamoto, S; Yamano, T | 1 |
| Gormsen, LC; Jochumsen, MR; Nielsen, GL | 1 |
| Furuya, S; Kasai, K; Kroenke, M; Manabe, O; Nanbu, T; Shinnno, Y; Tamaki, N; Yamashita, N | 1 |
| Dong, A; Lu, J; Wang, Y; Yang, B | 1 |
| Hasumi, H; Hayashi, N; Ikeda, I; Inoue, T; Izumi, K; Kaneta, T; Kawahara, T; Kishida, T; Kobayashi, K; Kondo, K; Makiyama, K; Minamimoto, R; Miyoshi, Y; Muraoka, K; Nakaigawa, N; Namura, K; Osaka, K; Tateishi, U; Teranishi, JI; Uemura, H; Ueno, D; Yao, M; Yumura, Y | 1 |
| Aguloglu, N; Altindag, S; Can, C; Karaoglan, H; Kepenek, F; Komek, H; Morcali, H | 1 |
| Chen, W; Kesari, V; Lee, CH; Legesse, T | 1 |
| Bian, Y; Hu, Y; Tian, C; Wei, Q; Wu, D | 1 |
| Liang, X; Liu, Y; Ran, P; Tang, M; Xu, C; Zhu, Y | 1 |
| Ahmed, S; Elahmadawy, MA; Elazab, MSS; Salama, M | 1 |
| Hu, F; Lan, X; Liu, F; Qin, C; Xia, X | 1 |
| Malkowski, B; Pankowska, V; Roszkowski, K; Wedrowska, E; Wedrowski, M | 1 |
| Akao, T; Hikami, K; Shibasaki, N; Ueda, M; Yasui, H | 1 |
| Chen, S; Cheng, KC; Ho, CL; Leung, YL; Wong, YH | 1 |
| Amoreo, CA; Costantini, M; Gallucci, M; Minisola, F; Poeta, ML; Pompeo, V; Sentinelli, S; Simone, G; Tuderti, G; Vallati, G | 1 |
| Bharati, J; Gupta, KL; Kavanal, AJ; Kumar, R; Mittal, BR; Vadi, SK | 1 |
| Dong, A; Wang, Y; Xiao, Z | 1 |
| Hasumi, H; Hayashi, N; Ikeda, I; Inoue, T; Izumi, K; Kaneta, T; Kawahara, T; Kobayashi, K; Kondo, K; Makiyama, K; Miyoshi, Y; Muraoka, K; Nakaigawa, N; Osaka, K; Tabei, T; Teranishi, JI; Uemura, H; Yao, M; Yumura, Y | 1 |
| Kumar, R; Mittal, BR; Nada, R; Rathi, M; Shukla, J; Singh, H; Sood, A | 1 |
| Chen, H; Chen, L; Duan, S; Ma, X; Ou, X; Shen, C; Wang, Y; Xu, H; Xu, W; Zhu, S | 1 |
| Gambhir, S; Ora, M; Parashar, A; Rangan B K, K; Suraj, AS | 1 |
| Berney, D; Bex, A; Blank, C; Boleti, E; Chowdhury, S; Haanen, J; Jones, R; Kayani, I; Lim, L; Peters, J; Powles, T; Reynolds, AR; Sahdev, A; Shamash, J; Sharpe, K; Stewart, GD | 1 |
| Bhattacharya, A; Bhoil, A; Gupta, V; Mittal, BR; Nijhawan, R; Rane, S | 1 |
| Ali, Z; Aurangabadkar, H | 1 |
| Ferda, J; Ferdova, E; Finek, J; Hes, O; Hora, M; Kreuzberg, B; Topolcan, O | 1 |
| Chung, JK; Edmund Kim, E; Kim, TM; Kwak, C; Lee, DS; Lee, SH; Paeng, JC; Park, YH; Yoon, HJ | 1 |
| Appelbaum, DE; Chen, JL; Cowey, CL; Kocherginsky, M; McDermott, DF; Rathmell, WK; Stadler, WM | 1 |
| Brown, RK; Corbett, JR; Murthy, VL | 1 |
| Bernardo, A; Brunocilla, E; Castellucci, P; Ceci, F; Chondrogiannis, S; Colletti, PM; D'Ambrosio, D; Fanti, S; Fuccio, C; Grassetto, G; Maffione, AM; Palumbo, R; Rubello, D; Schiavina, R; Spinapolice, EG; Trifirò, G | 1 |
| Hanai, T; Hattori, Y; Ishida, H; Koizumi, M; Kondo, K; Miyoshi, Y; Noguchi, K; Teranishi, J; Yoneyama, S; Yumura, Y | 1 |
| Brunetti, O; Dei Tos, AP; Gesualdo, L; Silvestris, F; Stucci, S; Tucci, M; Vallarelli, S | 1 |
| Hayashi, N; Ikeda, I; Inoue, T; Kakizoe, M; Kishida, T; Kobayashi, K; Kubota, Y; Makiyama, K; Minamimoto, R; Morita, S; Nakaigawa, N; Namura, K; Noguchi, S; Ohgo, Y; Sano, F; Taguri, M; Tateishi, U; Ueno, D; Yao, M | 1 |
| Blomqvist, LK; Farnebo, J; Grybäck, P; Harmenberg, U; Laurell, A; Sandström, P; Ullén, A; Wersäll, P | 1 |
| Alavi, A; Chauhan, MS; Hess, S; Jacob, MJ; Ravina, M | 1 |
| Fujimoto, S; Fukata, S; Fukuhara, H; Inoue, K; Kuroda, N; Matsumoto, M; Shuin, T; Taniguchi, Y; Terada, Y | 1 |
| Besiroglu, H; Dursun, M; Horsanali, MO; Otunctemur, A; Ozbek, E; Ozer, K; Polat, EC | 1 |
| Abe, H; Betsunoh, H; Fukabori, Y; Kaji, Y; Kamai, T; Kambara, T; Kitajima, K; Mizuno, T; Nishihara, D; Sakamoto, S; Yashi, M; Yoshida, K; Yuki, H | 1 |
| Bae, KT; Goshima, S; Hirose, Y; Kanematsu, M; Kawada, H; Kawai, N; Kondo, H; Matsunaga, K; Nishibori, H; Noda, Y; Suzui, N; Tanahashi, Y; Watanabe, H | 1 |
| Ozturk, H | 1 |
| Bouchelouche, K; Choyke, PL | 1 |
| Fujimura, T; Fukayama, M; Homma, Y; Koyama, K; Kume, H; Momose, T; Morikawa, T; Nakagawa, T; Ohtomo, K; Takahashi, M | 1 |
| Bird, N; Buscombe, J; Cheow, HK; Eisen, T; Fife, K; Gallagher, FA; Gerety, EL; Heard, S; Hilborne, S; Lawrence, EM; Lomas, DJ; Matakidou, A; Shaw, AS; Soloviev, D; Wason, J; Yan, H | 1 |
| Bassa, P; García Garzon, JR; Llinares, E; Moragas, M; Riera, E; Soler, M | 1 |
| Alongi, P; Evangelista, L; Gianolli, L; Picchio, M; Saladini, G; Spallino, M; Zattoni, F | 1 |
| Agarwal, N; Beardmore, B; Boucher, K; Butterfield, RI; Hoffman, JM; Horn, KP; Kadrmas, DJ; Morton, KA; Yap, JT | 1 |
| Fujita, K; Kida, H; Kusumi, F; Miyajima, S; Morisawa, T; Ohana, M; Okano, A; Okinaga, S; Omura, A; Takai, R | 1 |
| Allaf, ME; Gorin, MA; Hammers, HJ; Javadi, MS; Pomper, MG; Rowe, SP | 1 |
| Abe, K; Kondo, T; Nakajima, R; Sakai, S; Tanabe, K | 1 |
| Guo, Y; Wang, T | 1 |
| Adler, S; Anver, M; Bratslavsky, G; Choyke, PL; Eclarinal, P; Kurdziel, KA; Kwarteng, G; Lin, FI; Lindenberg, ML; Linehan, WM; McKinney, YL; Merino, MJ; Metwalli, AR; Turkbey, B; Vocke, CD; Weaver, J; Yaqub-Ogun, N | 1 |
| Hasumi, H; Ikeda, I; Inoue, T; Kaneta, T; Kishida, T; Kobayashi, K; Kondo, K; Kubota, Y; Makiyama, K; Minamimoto, R; Nakaigawa, N; Namura, K; Tateishi, U; Ueno, D; Yao, M | 1 |
| Kubota, K; Minamimoto, R; Nagashima, Y; Nakaigawa, N; Nakajima, K; Namura, K; Toyohara, J; Ueno, D; Yao, M | 1 |
| Joy, A; Nanabala, R; Sasikumar, A; Tk, P; Unni, M | 1 |
| Ge, J; Guan, Y; Liang, Z; Zuo, C | 1 |
| Alstrup, AK; Bender, D; Borghammer, P; Breining, P; Dagnæs-Hansen, F; Gormsen, LC; Jakobsen, S; Jørgensen, NP; Knudsen, K; Madsen, LB; Mortensen, FV; Petersen, MS; Schleimann, MH | 1 |
| Kuang, A; Liu, B; Ma, H; Ren, P; Shen, G; Yang, Y | 1 |
| Allaf, ME; Gorin, MA; Rowe, SP | 1 |
| Ikeda, I; Inoue, T; Kaneta, T; Kishida, T; Kobayashi, K; Kondo, K; Makiyama, K; Minamimoto, R; Nakaigawa, N; Namura, K; Shioi, K; Tateishi, U; Ueno, D; Yao, M | 1 |
| Grassi, P; Mennitto, A; Procopio, G; Ratta, R; Verzoni, E | 1 |
| Abe, K; Kondo, T; Matsuo, Y; Nakajima, R; Sakai, S | 1 |
| Djaileb, L; Mandry, D; Marie, PY; Riou, L; Verger, A | 1 |
| Cho, A; Choi, YD; Hwang, SH; Kang, WJ; Rha, SY; Yun, M | 1 |
| Divgi, C; Perini, R; Pryma, D | 1 |
| Jo, MK; Lee, HM; Park, JW | 1 |
| Aoki, K; Hirata, M; Hyodo, T; Miyagawa, M; Mochizuki, T; Murakami, M; Sugawara, Y; Tanji, N; Tsuda, T; Yanagihara, Y; Yokoyama, M | 1 |
| Boijsen, M; Lundstam, S; Lyrdal, D; Stierner, U; Suurküla, M | 1 |
| Heston, TF; Szabo, Z | 1 |
| Bauer, J; Delaloye, AB; Guillou, L; Marx, K; Prior, J | 1 |
| Basely, M; Bonnel, S; Bussy, E; de Jaureguiberry, JP; Maszelin, P; Verdalle, P | 1 |
| Chen, SW; Chen, YK; Yeh, CL | 1 |
| Higashi, T; Nakamoto, Y; Nakatani, K; Saga, T; Togashi, K | 1 |
| Anthony, MP; Khong, PL; Mak, H | 1 |
| Banzo, I; Barragán, J; Carril, JM; Jimenez-Bonilla, J; Martinez-Rodriguez, I; Medina-Quiroz, P; Portilla-Quattocciochi, H; Quirce, R; Sainz-Esteban, A | 1 |
| Hase, K; Hiraki, S; Ichikura, T; Ono, S; Sakamoto, N; Shimazaki, H; Sugasawa, H; Tsujimoto, H; Yaguchi, Y; Yamamoto, J | 1 |
| Ahn, BC; Jeong, SY; Kang, S; Lee, HJ; Lee, J; Lee, SW; Seo, JH; Song, BI | 1 |
| Avril, N; Dambha, F; Murray, I; Powles, T; Sahdev, A; Shamash, J | 1 |
| Bolton, DM; Davis, ID; Lawrentschuk, N; Scott, AM | 2 |
| Mueller-Lisse, UG; Mueller-Lisse, UL | 1 |
| Bu, ZB; Chen, LH; Ding, Y; Feng, J; Guan, J; Wang, QS; Wu, HB; Yang, RM; Ye, XH; Zhou, WL | 1 |
| Kumar, R; Shandal, V | 1 |
| Jeph, S; Kumar, R; Malhotra, A; Shamim, SA; Shandal, V; Singh, H | 1 |
| Brown, RK; Dunnick, NR; Frey, KA; Kochhar, R; Manoharan, P; Wong, CO | 1 |
| Araki, I; Hayama, S; Higashi, K; Ishikawa, I; Miyazawa, K; Morita, K; Nakazawa, T; Nojima, T; Suzuki, K | 1 |
| Bhattacharya, A; Kashyap, R; Manohar, K; Mittal, BR; Singh, B | 1 |
| Chachoua, A; Friedman, K; Probst, S; Seltzer, A | 1 |
| Hayashi, N; Inoue, T; Ishigaki, H; Kishida, T; Kobayashi, K; Kubota, Y; Makiyama, K; Minamimoto, R; Miura, T; Murakami, T; Nakaigawa, N; Namura, K; Noguchi, S; Sano, F; Tateishi, U; Yao, M | 1 |
| Fjeld, JG; Fosså, SD; Hagen, G; Lilleby, W; Revheim, ME; Winge-Main, AK | 1 |
| Ho, L; Kaushik, A | 1 |
| Inoue, T; Kishida, T; Kubota, Y; Makiyama, K; Minamimoto, R; Miura, T; Nakaigawa, N; Shizukuishi, K; Suzuki, A; Tateishi, U; Yao, M | 1 |
| Cenkowski, M; Czaykowski, PM; Gibson, IW; Lategan, B | 1 |
| Ozbek, E; Ozpaçaci, T; Ozülker, F; Ozülker, T | 1 |
| Aoyagi, T; Kubota-Chikai, K; Kuroda, N; Nonomura, K; Shinohara, N | 1 |
| Bacharach, SL; Buvat, I; Carrasquillo, JA; Carson, JM; Hapdey, S; Whatley, M | 1 |
| Gadodia, A; Kumar, R; Malhotra, A; Shamim, SA; Shandal, V; Sharma, P | 1 |
| de Geus-Oei, LF; Gilles, R; Mulders, PF; Oyen, WJ | 1 |
| Avril, N; Bomanji, J; Chowdhury, S; Dickson, J; Ell, P; Kayani, I; Lim, L; Nathan, P; Powles, T; Reynolds, A; Rockall, A; Sahdev, A; Shamash, J; Sharpe, K; Wilson, P | 1 |
| George, DJ; Harrison, MR | 1 |
| Finkenzeller, T; Framme, C; Helbig, H; Hufendiek, K | 1 |
| Dechet, C; Heilbrun, M; Willis, H | 1 |
| Hayashi, N; Ikeda, I; Inoue, T; Kishida, T; Kobayashi, K; Kubota, Y; Makiyama, K; Minamimoto, R; Miura, T; Murakami, T; Nakaigawa, N; Noguchi, S; Ohgo, Y; Sano, F; Tateishi, U; Ueno, D; Yao, M | 1 |
| Muthukrishnan, A; Pinnamaneni, N | 1 |
| Cowey, CL; Gohil, H; Khandani, AH; Moore, DT; Rathmell, WK | 1 |
| Revannasiddaiah, S; Sharma, M; Sood, A; Thakur, P | 1 |
| Bertagna, F; Cunico, SC; Fisogni, S; Giubbini, R; Simeone, C; Tardanico, R | 1 |
| Chao, CH; Chen, JH; Ding, HJ; Kao, CH; Lin, WY; Lu, YY; Wang, HY | 1 |
| Kaya, B; Sari, O; Varoglu, E | 1 |
| Abrar, ML; Bhattacharya, A; Dey, P; Mandal, AK; Manohar, K; Mittal, BR; Vyas, S | 1 |
| Kao, CH; Lee, CC; Lin, CC; Shen, YY; Wu, HC; Yen, RF | 1 |
| Brouwers, AH; Mulders, PF; Oyen, WJ; Steffens, MG | 1 |
| Aigner, RM; Humer-Fuchs, U; Krippl, P; Schwarz, T; Wehrschuetz, M; Wolf, G | 1 |
| Bacharach, SL; Carrasquillo, JA; Carson, JM; Freedman, NM; Kurdziel, K; Libutti, SK; Sellers, D; Sundaram, SK; Whatley, M; Yang, JC | 1 |
| Chang, CH; Kao, A; Lee, CC; Lin, CC; Shen, YY; Shiau, YC | 1 |
| Albani, JM; Bukowski, RM; Elson, P; Kanvinde, MH; Majhail, NS; Mekhail, TM; Novick, AC; Olencki, TE; Rice, TW; Urbain, JL | 1 |
| Conti, PS; Jadvar, H; Kherbache, HM; Pinski, JK | 1 |
| Kang, DE; Sasser, HC; Teigland, CM; White, RL; Zuger, JH | 1 |
| Boerman, O; Brouwers, A; Corstens, F; Oosterwijk, E; Oyen, W; Steffens, M; Van Dongen, G; Van Eerd, J; Verel, I; Visser, G | 1 |
| Balan, KK; Cheow, HK; Joseph, JA | 1 |
| Larson, SM; Schöder, H | 1 |
| Nguyen, BD | 1 |
| Hinohara, S; Ide, M; Kameyama, G; Kawada, S; Koide, S; Suzuki, Y; Takahashi, W | 1 |
| Arzumanov, AA; Granov, AM; Karelin, MI; Kostenikov, NA; Ryzhkova, DV; Shkol'nik, MI; Stanzhevskiĭ, AA; Tlostanova, MS | 1 |
| Ak, I; Can, C | 1 |
| Curry, NS; Gordon, L; Kavanagh, JJ; Ravenel, JG | 1 |
| García, JR; Huguet, M; Lomeña, F; Simo, M; Ysamat, M | 1 |
| Connolly, LP; Drubach, LA; Kourmouzi, V; Voss, SD | 1 |
| Chang, CY; Chen, CY; Cheng, CY; Cherng, SC; Chiu, CS; Fan, YM | 1 |
| Bryant, AS; Cerfolio, RJ | 1 |
| Fulham, MJ; Mohamed, A; O' Neill, GF; Thambugala, GM | 1 |
| de Clermont, H; Dilhuydy, MS; Durieux, A; Monteil, J; Pariente, A; Pasticier, G; Ravaud, A | 1 |
| Chen, X; Dai, JZ; Dong, MJ; Guan, YH; Jiang, BD; Lin, XT; Zhao, J; Zuo, CT | 1 |
| Hahm, GK; Jacobs, MP; Mantil, JC; Sizemore, AW | 1 |
| Agrawal, A; Baghel, N; Nair, N | 1 |
| Hamazawa, Y; Ikemoto, S; Inoue, Y; Koyama, K; Okamura, T; Ozawa, N; Senzaki, H; Tanabe, S | 1 |
| Abhyankar, A; Awasare, S; Malhotra, G; Moghe, SH; Nair, N | 1 |
| Celik, M; Erbagci, A; Erturhan, S; Karakok, M; Seçkiner, I; Yagci, F; Zincirkeser, S | 1 |
| Bachor, R; Gropengiesser, F; Hautmann, RE; Kocher, F; Reske, SN | 1 |
| Aoki, S; Fujii, H; Kosuda, S; Nakamura, O; Shitara, N; Suzuki, K; Tanaka, Y | 1 |
| Bachor, R; Brändle, E; Gottfried, HW; Hautmann, R; Kotzerke, J; Reske, SN | 1 |
| Eary, JF; Gold, P; Guinee, DG; Mankoff, DA; Samlowski, WE; Thompson, JA | 1 |
| Costa de Beauregard, MA; Doublet, JD; Gattegno, B; Grahek, D; Kerrou, K; Montravers, F; Rossert, J; Talbot, JN; Thibault, P; Younsi, N | 1 |
| Alavi, A; Duarte, PS; Li, P; Pourdehnad, M; Zhuang, H | 1 |
| Ackermann, R; Börner, AR; Coenen, HH; Hamacher, K; Herzog, H; Langen, KJ; Müller-Mattheis, V | 1 |
| Berlangieri, SU; Bolton, DM; Danguy, HT; Davis, I; Macgregor, D; Ramdave, S; Scott, AM; Thomas, GW | 1 |
| Buttman, JA; Fuller, B; Hewitt, SM; Patronas, N; Poggi, MM | 1 |
| Avril, N; Breul, J; Hartung, R; Hofer, C; Kübler, H | 1 |
| Czernin, J; Figlin, R; Hoh, CK; Phelps, ME; Safaei, A; Seltzer, M; Silverman, DH | 1 |
| Bihl, H; Boerman, OC; Brouwers, AH; Corstens, FH; Dorr, U; Lang, O; Mergenthaler, HG; Oosterwijk, E; Oyen, WJ; Steffens, MG | 1 |
| Algan, O; Hanson, JM; Kinsella, TJ; Levin, AB; Levine, RL; Mehta, MP; Mendoza, M; Nickles, RJ; Rozental, JM; Schrader, DA | 1 |
| Fujita, T; Hida, S; Kawamura, J; Konishi, J; Saji, H; Senda, M; Yamamoto, K; Yonekura, Y; Yoshida, O | 1 |
16 review(s) available for fluorodeoxyglucose f18 and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
Diagnostic performance of MRI, SPECT, and PET in detecting renal cell carcinoma: a systematic review and meta-analysis.
Topics: Adult; Aged; Carcinoma, Renal Cell; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Young Adult | 2022 |
Role of Positron Emission Tomography Imaging in Metabolically Active Renal Cell Carcinoma.
Topics: Carcinoma, Renal Cell; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2019 |
MicroRNAs and altered metabolism of clear cell renal cell carcinoma: Potential role as aerobic glycolysis biomarkers.
Topics: Aerobiosis; Biomarkers; Carcinoma, Renal Cell; Citric Acid Cycle; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Glucose Transporter Type 4; Glycolysis; Humans; Kidney Neoplasms; MicroRNAs; Positron-Emission Tomography | 2017 |
Sarcomatoid renal cell carcinoma: a case report and literature review.
Topics: Carcinoma, Renal Cell; Disease Progression; Fatal Outcome; Fluorodeoxyglucose F18; Hematuria; Humans; Kidney Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rhabdomyosarcoma; Tomography, X-Ray Computed | 2018 |
Metachronous Isolated Splenic Metastasis in a Young Patient With Renal Cell Carcinoma: Case Report and Literature Review.
Topics: Adult; Biopsy, Needle; Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunohistochemistry; Laparoscopy; Male; Neoplasms, Second Primary; Nephrectomy; Positron Emission Tomography Computed Tomography; Risk Assessment; Splenectomy; Splenic Neoplasms; Time Factors; Treatment Outcome | 2019 |
PET/Computed Tomography in Renal, Bladder, and Testicular Cancer.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Testicular Neoplasms; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2015 |
Diagnostic performance of 18F-FDG PET or PET/CT in restaging renal cell carcinoma: a systematic review and meta-analysis.
Topics: Carcinoma, Renal Cell; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2017 |
Molecular imaging of renal cell carcinoma.
Topics: Acetates; Antibodies, Monoclonal; Antigens, Neoplasm; Carbon; Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Genetic Markers; Humans; Iodine Radioisotopes; Kidney Neoplasms; Molecular Probe Techniques; Positron-Emission Tomography; Radioactive Tracers | 2008 |
The clinical advances of fluorine-2-D-deoxyglucose--positron emission tomography/computed tomography in urological cancers.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed; Urinary Bladder Neoplasms; Urologic Neoplasms | 2010 |
Functional imaging of renal cell carcinoma.
Topics: Carcinoma, Renal Cell; Decision Making; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymph Nodes; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radioimmunodetection; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
Imaging of advanced renal cell carcinoma.
Topics: Carcinoma, Renal Cell; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Magnetic Resonance Imaging; Male; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Radiographic Image Enhancement; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Doppler | 2010 |
Role of FDG PET/CT in imaging of renal lesions.
Topics: Adenoma, Oxyphilic; Angiomyolipoma; Carcinoma, Renal Cell; Cysts; Fluorodeoxyglucose F18; Humans; Incidental Findings; Kidney; Kidney Diseases; Kidney Neoplasms; Leukemia; Lymphoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
Meta-analysis of the diagnostic performance of [18F]FDG-PET and PET/CT in renal cell carcinoma.
Topics: Carcinoma, Renal Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2012 |
Positron emission tomography for prostate, bladder, and renal cancer.
Topics: Carcinoma, Renal Cell; Clinical Trials as Topic; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Treatment Outcome; Urinary Bladder Neoplasms | 2004 |
Positron emission tomography (PET), immuno-PET and radioimmunotherapy in renal cell carcinoma: a developing diagnostic and therapeutic relationship.
Topics: Acetates; Carcinoma, Renal Cell; Choline; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Neoplasm Staging; Nitroimidazoles; Positron-Emission Tomography; Radioimmunodetection; Radioimmunotherapy; Radiopharmaceuticals | 2006 |
Diagnosis and monitoring of urological tumors using positron emission tomography.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Prostatic Neoplasms; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Tomography, Emission-Computed; Urinary Bladder Neoplasms; Urogenital Neoplasms | 2001 |
13 trial(s) available for fluorodeoxyglucose f18 and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
Semi-quantitative F-18-FDG PET/computed tomography parameters for prediction of grade in patients with renal cell carcinoma and the incremental value of diuretics.
Topics: Carcinoma, Renal Cell; Diuretics; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Grading; Positron Emission Tomography Computed Tomography; ROC Curve | 2020 |
Evaluation of treatment response and resistance in metastatic renal cell cancer (mRCC) using integrated
Topics: Adult; Aged; Axitinib; Bevacizumab; Carcinoma, Renal Cell; Cell Proliferation; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Imidazoles; Indazoles; Indoles; London; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasms, Second Primary; Positron-Emission Tomography; Pyrimidines; Pyrroles; Sulfonamides; Sunitinib; Treatment Outcome | 2017 |
Early assessment with
Topics: Aged; Antineoplastic Agents, Immunological; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Nivolumab; Positron Emission Tomography Computed Tomography; Prognosis | 2019 |
A prospective evaluation of VEGF-targeted treatment cessation in metastatic clear cell renal cancer.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Carcinoma, Renal Cell; Disease-Free Survival; Drug Administration Schedule; Female; Fluorodeoxyglucose F18; Humans; Indazoles; Indoles; Kidney Neoplasms; Male; Middle Aged; Molecular Targeted Therapy; Neoplasm Metastasis; Nephrectomy; Positron-Emission Tomography; Prospective Studies; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Radiopharmaceuticals; Sulfonamides; Sunitinib; Treatment Outcome; Vascular Endothelial Growth Factor A; Withholding Treatment | 2013 |
FDG-PET as a predictive biomarker for therapy with everolimus in metastatic renal cell cancer.
Topics: Adult; Aged; Antineoplastic Agents; Biomarkers; Carcinoma, Renal Cell; Everolimus; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Sirolimus; Treatment Outcome; Tumor Burden | 2013 |
FDG and FLT-PET for Early measurement of response to 37.5 mg daily sunitinib therapy in metastatic renal cell carcinoma.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antineoplastic Agents; Carcinoma, Renal Cell; Dideoxynucleosides; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Indoles; Kidney Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Pyrroles; Radiopharmaceuticals; Sunitinib; Treatment Outcome | 2015 |
Evaluation of sorafenib treatment in metastatic renal cell carcinoma with 2-fluoro-2-deoxyglucose positron emission tomography and computed tomography.
Topics: Aged; Benzenesulfonates; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Niacinamide; Phenylurea Compounds; Positron-Emission Tomography; Pyridines; Sorafenib; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Evaluation of response to multikinase inhibitor in metastatic renal cell carcinoma by FDG PET/contrast-enhanced CT.
Topics: Adult; Aged; Carcinoma, Renal Cell; Contrast Media; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Protein Kinase Inhibitors; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Sequential FDG-PET/CT as a biomarker of response to Sunitinib in metastatic clear cell renal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Indoles; Kaplan-Meier Estimate; Kidney Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Pyrroles; Sunitinib; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Primary renal cell carcinoma: relationship between 18F-FDG uptake and response to neoadjuvant sorafenib.
Topics: Adult; Aged; Aged, 80 and over; Benzenesulfonates; Biological Transport; Carcinoma, Renal Cell; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Niacinamide; Phenylurea Compounds; Positron-Emission Tomography; Pyridines; Safety; Sorafenib; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2012 |
F-18 FDG PET in detecting renal cell carcinoma.
Topics: Aged; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Kidney Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results | 2005 |
Prediction of survival in patients with suspected recurrent cerebral tumors by quantitative thallium-201 single photon emission computed tomography.
Topics: Adenocarcinoma; Adult; Age Factors; Aged; Astrocytoma; Brain Neoplasms; Carcinoma, Renal Cell; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Humans; Kidney Neoplasms; Male; Middle Aged; Predictive Value of Tests; Prognosis; Survival Rate; Teratoma; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 1994 |
131 I-cG250 monoclonal antibody immunoscintigraphy versus [18 F]FDG-PET imaging in patients with metastatic renal cell carcinoma: a comparative study.
Topics: Aged; Antibodies, Monoclonal; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Kidney Neoplasms; Male; Middle Aged; Radiography; Radionuclide Imaging; Radiopharmaceuticals | 2002 |
179 other study(ies) available for fluorodeoxyglucose f18 and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
Prognostic importance of SUVmax values evaluated by 18F-FDG-PET/CT before nivolumab treatment in patients with metastatic renal cell carcinoma.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Nivolumab; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2023 |
The role of dual tracer PSMA and FDG PET/CT in renal cell carcinoma (RCC) compared to conventional imaging: A multi-institutional case series with intra-individual comparison.
Topics: Aged; Carcinoma, Renal Cell; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2022 |
Sunitinib-Induced Myositis Detected on 18F-FDG PET/CT.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Myositis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sunitinib | 2022 |
18F-FDG PET/CT and 99mTc-MIBI SPECT/CT Findings in a Patient With Eosinophilic Solid and Cystic Renal Cell Carcinoma.
Topics: Adult; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Positron Emission Tomography Computed Tomography; Single Photon Emission Computed Tomography Computed Tomography; Technetium Tc 99m Sestamibi | 2022 |
A Renal Cyst Invaded by Infiltrating Renal Cell Carcinoma With Multiple Hypermetabolic Bone Metastases as the Initial Presentation.
Topics: Carcinoma, Renal Cell; Cysts; Fluorodeoxyglucose F18; Humans; Kidney Diseases, Cystic; Kidney Neoplasms; Positron Emission Tomography Computed Tomography | 2022 |
Role of 18F-FDG PET/CT in the assessment of therapy response and clinical outcome in metastatic renal cell carcinoma treated with tyrosine kinase inhibitors or immunotherapy.
Topics: Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Immunotherapy; Kidney Neoplasms; Male; Positron Emission Tomography Computed Tomography; Protein Kinase Inhibitors; Radiopharmaceuticals | 2022 |
Focal Xanthogranulomatous Pyelonephritis on FDG PET/CT.
Topics: Aged; Carcinoma, Renal Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Positron Emission Tomography Computed Tomography; Pyelonephritis, Xanthogranulomatous | 2022 |
Nivolumab Immunotherapy-Related Skin Reactions Detected on 18F-FDG PET/CT in Renal Cell Cancer.
Topics: Antineoplastic Agents, Immunological; Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Immunotherapy; Kidney Neoplasms; Nivolumab; Positron Emission Tomography Computed Tomography; Programmed Cell Death 1 Receptor | 2022 |
Gallbladder Metastasis From Renal Cell Carcinoma Revealed With 18 F-FDG PET/CT.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Kidney Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed | 2022 |
FDG PET/CT in Eosinophilic Solid and Cystic Renal Cell Carcinoma With Lung Metastases.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tomography, X-Ray Computed | 2022 |
FDG PET/CT in a Case With Cellular Schwannoma of the Kidney.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Kidney Pelvis; Neurilemmoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tomography, X-Ray Computed | 2022 |
Lipid-Poor Renal Angiomyolipoma Mimicking Renal Cell Carcinoma on 68 Ga-FAPI-04 PET/CT.
Topics: Angiomyolipoma; Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Gallium Radioisotopes; Hamartoma; Humans; Kidney Neoplasms; Lipids; Positron Emission Tomography Computed Tomography; Quinolines | 2022 |
Metastasis From Clear Cell Renal Cell Carcinoma Mimicking Well-Differentiated Pancreatic Neuroendocrine Tumor at 18F-FDG and 68Ga-DOTATOC PET/CT.
Topics: Aged, 80 and over; Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Neuroectodermal Tumors, Primitive; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2022 |
68Ga-FAPI-04 PET/CT in Solitary Choroid Plexus Metastasis From Renal Cell Carcinoma.
Topics: Carcinoma, Renal Cell; Choroid Plexus; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines | 2022 |
A Von Hippel-Lindau Disease-Associated Microcystic Adenoma of the Ethmoid Sinus Mimicking Metastatic Clear Cell Renal Cell Carcinoma.
Topics: Adenoma; Adult; Carcinoma, Renal Cell; Ethmoid Sinus; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Positron Emission Tomography Computed Tomography; von Hippel-Lindau Disease | 2023 |
Prognostic value of maximum standard uptake value, metabolic tumor volume, and total lesion glycolysis of 18F-FDG PET/CT in patients with renal carcinoma: A protocol for systematic review and meta analysis: Erratum.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Glycolysis; Humans; Kidney Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2022 |
Role of 18F-FDG PET/CT for detection of recurrence and metastases in renal cell carcinoma-are we underusing PET/CT?
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2022 |
Superiority of 68Ga-FAPI-04 in Delineation of Soft Tissue and Liver Metastases in Chromophobe Renal Cell Carcinoma for Restaging.
Topics: Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Liver Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography | 2022 |
FDG-PET Positivity and Overall Survival in Renal Cell Carcinoma.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Positron-Emission Tomography | 2022 |
[89Zr]Zr-DFO-girentuximab and [18F]FDG PET/CT to Predict Watchful Waiting Duration in Patients with Metastatic Clear-cell Renal Cell Carcinoma.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Prognosis; Radioisotopes; Radiopharmaceuticals; Watchful Waiting; Zirconium | 2023 |
Prognostic significance of 18F-FDG PET/CT indices in metastatic renal cell cancer and evaluation of revised IMDC risk model by including 18F-FDG PET-CT parameters.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2023 |
Isolated Urinary Bladder Metastasis in Renal Cell Carcinoma Detected on 18F-FDG PET/CT Scan.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Urinary Bladder | 2023 |
68 Ga-FAPI-04 PET/CT and 18 F-FDG PET/CT in Metastatic Papillary Renal Cell Cancer.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Kidney Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography | 2023 |
68 Ga-FAPI-04 PET/CT in a Small Sarcomatoid Renal Cell Carcinoma With Widespread Metastases.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Kidney Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines | 2023 |
The Isolated Humeral Metastasis as the Initial Presentation of Renal Cell Carcinoma Revealed by 18 F-FDG PET/CT.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Humerus; Kidney Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed | 2023 |
The value of PET/CT for the diagnosis and evaluation of immunotherapy in occult primary renal cell carcinoma: a case report.
Topics: Aged; Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Immunotherapy; Kidney Neoplasms; Male; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Soft Tissue Neoplasms; Tumor Burden | 2023 |
68Ga-PSMA PET/CT Detecting Metastatic Lesion of RCC: Missed on 18F-FDG PET/CT.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Kidney Neoplasms; Positron Emission Tomography Computed Tomography | 2023 |
A Head-to-Head Comparison of 68Ga-LNC1007 and 2-18F-FDG/68Ga-FAPI-02 PET/CT in Patients With Various Cancers.
Topics: Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Liver Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography | 2023 |
68 Ga-LNC-1007 PET/CT Imaging in a Patient With Renal Cell Carcinoma Compared With 68 Ga-PSMA-11 PET/CT.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Oligopeptides; Positron Emission Tomography Computed Tomography | 2023 |
FDG PET/CT Findings of Renal Cell Carcinoma Arising From a Transplanted Kidney in a Pediatric Patient.
Topics: Carcinoma, Renal Cell; Child; Female; Fluorodeoxyglucose F18; Humans; Kidney; Kidney Neoplasms; Kidney Transplantation; Lymphoproliferative Disorders; Positron Emission Tomography Computed Tomography | 2023 |
Isolated Nasal Metastasis From Renal Cell Carcinoma 9 Years After Nephrectomy Seen on FDG PET.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Nose Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2020 |
Giant Epithelioid Angiomyolipoma: An Imaging-related Differential Diagnosis Among Fat-containing Renal Masses.
Topics: Adult; Angiomyolipoma; Carcinoma, Renal Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Kidney; Kidney Neoplasms; Leiomyoma; Leiomyosarcoma; Magnetic Resonance Imaging; Male; Nephrectomy; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2020 |
Heterogeneous response to target therapy in metastatic papillary renal cell carcinoma evaluated by morphologic and metabolic multimodality imaging: A case report.
Topics: Adult; Bone Neoplasms; Carcinoma, Renal Cell; Combined Modality Therapy; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Laparoscopy; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Multimodal Imaging; Neck; Neoplasm Staging; Nephrectomy; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thoracic Vertebrae | 2019 |
Pyrexia of unknown origin as clinical presentation of Renal Cell Carcinoma: Role of F18-FDG PET/CT.
Topics: Adult; Blood Sedimentation; C-Reactive Protein; Carcinoma, Renal Cell; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Nephrectomy; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Ultrasonography | 2020 |
Renal granulomas mimicking as malignant renal masses on F18 FDG PET/CT in a case of urothelial carcinoma.
Topics: Carcinoma; Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Granuloma; Humans; Kidney Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2020 |
68Ga-PSMA PET/CT and 18F-FDG PET/CT in Renal Cell Carcinoma.
Topics: Aged; Bone Neoplasms; Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Kidney Neoplasms; Male; Membrane Glycoproteins; Middle Aged; Organometallic Compounds; Positron Emission Tomography Computed Tomography | 2020 |
COVID-19 Pneumonia Mimicking Immunotherapy-Induced Pneumonitis on 18F-FDG PET/CT in a Patient Under Treatment With Nivolumab.
Topics: Betacoronavirus; Carcinoma, Renal Cell; Coronavirus Infections; COVID-19; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Immunotherapy; Kidney Neoplasms; Male; Middle Aged; Nivolumab; Pandemics; Pneumonia; Pneumonia, Viral; Positron Emission Tomography Computed Tomography; SARS-CoV-2 | 2020 |
Case report: a nonfunctioning juxtaglomerular cell tumor mimicking renal cell carcinoma.
Topics: Adult; Aftercare; Carcinoma, Renal Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Juxtaglomerular Apparatus; Kidney Neoplasms; Laparoscopy; Neoplasms; Nephrectomy; Positron Emission Tomography Computed Tomography; Robotic Surgical Procedures; Treatment Outcome | 2020 |
Comparison of 18F-DCFPyL and 18F-FDG PET/computed tomography for the restaging of clear cell renal cell carcinoma: preliminary results of 15 patients.
Topics: Aged; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lysine; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Recurrence; Retrospective Studies; Urea | 2020 |
Atrial Metastasis From Sarcomatoid Renal Cell Carcinoma: Integration Between 18F-FDG PET/CT and Cardiac 3-Dimensional Volume Rendering.
Topics: Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Heart Atria; Heart Neoplasms; Humans; Imaging, Three-Dimensional; Kidney Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography | 2020 |
Epithelioid Hemangioma of Vertebra Mimicking Metastasis on FDG PET/CT in a Patient With Renal Cell Cancer.
Topics: Carcinoma, Renal Cell; Diagnosis, Differential; Endothelial Cells; Female; Fluorodeoxyglucose F18; Hemangioma; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Spinal Neoplasms | 2021 |
Clinical utility of FDG PET/CT for primary and recurrent papillary renal cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Young Adult | 2021 |
Topics: Carcinoma, Renal Cell; Cell Differentiation; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Positron Emission Tomography Computed Tomography; Reproducibility of Results; Retrospective Studies | 2021 |
Complementary Role of 68Ga-Prostate-Specific Membrane Antigen and 18F-FDG PET/CT for Evaluation of Metastases and Treatment Response in Renal Cell Carcinoma.
Topics: Aged; Carcinoma, Renal Cell; Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Oligopeptides; Positron Emission Tomography Computed Tomography; Treatment Outcome | 2021 |
Topics: Adult; Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Kidney Neoplasms; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2021 |
Role of F-18 FDG PET/CT in the follow-up of asymptomatic renal cell carcinoma patients for postoperative surveillance: based on conditional survival analysis.
Topics: Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney; Kidney Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Postoperative Period; Radiometry; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed | 2022 |
A Rare Collecting Duct Carcinoma With Widespread Metastasis Visualized by 18F-FDG PET/CT.
Topics: Aged; Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2022 |
18F-FDG and 68GA-Prostate-Specific Membrane Antigen PET/CT Perform Better Than CT Alone in Restaging Papillary Renal Cell Carcinoma Recurrence.
Topics: Aged; Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prostate | 2021 |
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2021 |
One-month assessment of renal cell carcinoma treated by everolimus using FDG PET/CT predicts progression-free and overall survival.
Topics: Aged; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Renal Cell; Disease-Free Survival; Everolimus; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed | 2017 |
Irreversible Electroporation to Treat Malignant Tumor Recurrences Within the Pelvic Cavity: A Case Series.
Topics: Aged; Carcinoma, Renal Cell; Electroporation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rectal Neoplasms; Retrospective Studies; Sigmoid Neoplasms; Treatment Outcome; Uterine Cervical Neoplasms | 2017 |
Evaluation of renal cell carcinoma histological subtype and fuhrman grade using
Topics: Aged; Carcinoma, Papillary; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Grading; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Statistics, Nonparametric | 2017 |
Port site recurrence after laparoscopic radical nephrectomy: a case report.
Topics: Aged; Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Laparoscopy; Male; Neoplasm Recurrence, Local; Nephrectomy; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Treatment Outcome | 2017 |
Topics: Carcinoma, Renal Cell; Choline; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography | 2017 |
68Ga-PSMA Avid Primary Adenocarcinoma of the Lung With Complementary Low 18F-FDG Uptake.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Biological Transport; Carcinoma, Renal Cell; Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Oligopeptides; Positron Emission Tomography Computed Tomography | 2018 |
Renal Mucinous Tubular and Spindle Cell Carcinoma Shows a High Uptake on
Topics: Adenocarcinoma, Mucinous; Aged, 80 and over; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2018 |
Castleman's Disease of the Kidney Mimicking Renal Cell Carcinoma on FDG PET/CT.
Topics: Aged; Carcinoma, Renal Cell; Castleman Disease; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
FDG PET/CT after first molecular targeted therapy predicts survival of patients with renal cell carcinoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Papillary; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kidney Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Molecular Targeted Therapy; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate | 2018 |
The Effect on Survival and Mortality of the Highest SUVmax Value on Metastatic Foci in Postoperative Kidney Tumors.
Topics: Adult; Aged; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Kidney Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postoperative Period; Predictive Value of Tests; Preoperative Care; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden | 2018 |
FDG PET/CT of Chromophobe Renal Cell Carcinoma With Sarcomatoid Differentiation.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Three Primary Carcinomas on 18F-FDG PET/CT: Intrahepatic Cholangiocarcinoma, Papillary Renal Cell Carcinoma, and Clear Cell Renal Cell Carcinoma.
Topics: Aged; Bile Duct Neoplasms; Carcinoma, Renal Cell; Cholangiocarcinoma; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Diagnostic value of F-18 FDG PET/CT for local and distant disease relapse surveillance in surgically treated RCC patients: Can it aid in establishing consensus follow up strategy?
Topics: Adult; Aged; Carcinoma, Renal Cell; Consensus; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Nephrectomy; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2018 |
Intense Choline Activity in Renal Cell Carcinoma Without Obvious 18F-FDG Uptake.
Topics: Carcinoma, Renal Cell; Choline; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
FDG PET/CT as a survival prognostic factor in patients with advanced renal cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Mitogen-Activated Protein Kinases; Positron Emission Tomography Computed Tomography; Prognosis; Survival Analysis | 2019 |
[A Case of Renal Cell Carcinoma withIpsilateral Renal Pelvic Metastasis Mimicking Double Cancer].
Topics: Aged; Carcinoma, Renal Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Kidney Pelvis; Male; Nephrectomy; Positron Emission Tomography Computed Tomography | 2018 |
Dual-Tracer PET/CT Differentiates 2 Types of Primary Cancers and Metastases in a Patient With Crossed Fused Renal Ectopia.
Topics: Acetates; Carbon Radioisotopes; Carcinoma, Renal Cell; Colonic Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Kidney; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Radioactive Tracers | 2019 |
18F-FDG PET/CT Demonstrates Renal Cell Cancer in a Transplant With Synchronous Intestinal Infection.
Topics: Biopsy; Carcinoma, Renal Cell; Endoscopy; Fluorodeoxyglucose F18; Humans; Intestines; Kidney Neoplasms; Kidney Transplantation; Male; Positron Emission Tomography Computed Tomography; Tuberculosis; Young Adult | 2019 |
Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome-Associated Renal Cell Carcinoma Showing High FDG Uptake.
Topics: Adult; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Leiomyomatosis; Neoplastic Syndromes, Hereditary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Skin Neoplasms; Uterine Neoplasms | 2019 |
68Ga CXCR-4 PET/CT Imaging in an Atypical Case of Extramedullary Plasmacytoma Mimicking as Renal Cell Carcinoma.
Topics: Aged; Carcinoma, Renal Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Kidney Neoplasms; Male; Organometallic Compounds; Plasmacytoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptors, CXCR4 | 2019 |
Differential diagnostic ability of 18F-FDG PET/CT radiomics features between renal cell carcinoma and renal lymphoma.
Topics: Aged; Carcinoma, Renal Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; ROC Curve; Software | 2021 |
Rapidly Progressing Renal Cell Cancer of the Left Native Kidney in a Renal Transplant Recipient With Unusual Sites of Metastasis Demonstrated in Serial 18F-FDG PET/CT.
Topics: Carcinoma, Renal Cell; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Kidney; Kidney Neoplasms; Kidney Transplantation; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography | 2019 |
Renal cell carcinoma presenting as isolated deltoid muscle metastasis 12 years after radical nephrectomy detected on 18F-FDG PET/CT.
Topics: Aged; Carcinoma, Renal Cell; Deltoid Muscle; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Muscle Neoplasms; Nephrectomy; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Unusual metastatic sites from renal cell carcinoma detected by 18F-FDG PET/CT scan.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
18F-FDG-PET/CT in potentially advanced renal cell carcinoma: a role in treatment decisions and prognosis estimation.
Topics: Aged; Aged, 80 and over; Angiography; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney; Kidney Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Analysis; Tomography, X-Ray Computed | 2013 |
Prognostic implication of extrarenal metabolic tumor burden in advanced renal cell carcinoma treated with targeted therapy after nephrectomy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Molecular Targeted Therapy; Nephrectomy; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed | 2013 |
Metastatic renal cell carcinoma avid for 82Rb but not 18F-FDG.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Myocardial Stunning; Positron-Emission Tomography; Radiopharmaceuticals; Rubidium Radioisotopes; Thoracic Neoplasms | 2014 |
Restaging clear cell renal carcinoma with 18F-FDG PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
[Case of renal cell carcinoma with intertrabecular vertebral metastases detected f-18 fluorodeoxyglucose positron emission tomography and MRI].
Topics: Adult; Biomarkers, Tumor; Bone Marrow; C-Reactive Protein; Carcinoma, Renal Cell; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Laparoscopy; Lumbar Vertebrae; Magnetic Resonance Imaging; Nephrectomy; Positron-Emission Tomography; Radiopharmaceuticals; Spinal Neoplasms | 2014 |
Paraneoplastic focal segmental glomerulosclerosis in sarcomatoid renal cell cancer.
Topics: Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Deoxycytidine; Diagnosis, Differential; Drug Administration Schedule; Fluorodeoxyglucose F18; Gemcitabine; Glomerulosclerosis, Focal Segmental; Humans; Hypertension; Kidney Neoplasms; Lymph Node Excision; Male; Nephrectomy; Obesity; Paraneoplastic Syndromes; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging | 2015 |
The early response of renal cell carcinoma to tyrosine kinase inhibitors evaluated by FDG PET/CT was not influenced by metastatic organ.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Protein Kinase Inhibitors; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Volumetric FDG-PET predicts overall and progression- free survival after 14 days of targeted therapy in metastatic renal cell carcinoma.
Topics: Aged; Carcinoma, Renal Cell; Cone-Beam Computed Tomography; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Indazoles; Indoles; Kaplan-Meier Estimate; Male; Middle Aged; Molecular Targeted Therapy; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Protein-Tyrosine Kinases; Pyrimidines; Pyrroles; Sulfonamides; Sunitinib; Treatment Outcome | 2014 |
Tumor thrombus: ancillary findings on FDG PET/CT in an oncologic population.
Topics: Adolescent; Adult; Aged; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Child; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasms; Portal Vein; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thrombosis; Tomography, X-Ray Computed; Veins; Vena Cava, Inferior; Venous Thromboembolism; Young Adult | 2014 |
IgG4-related tubulointerstitial nephritis accompanied with cystic formation.
Topics: Carcinoma, Renal Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Immunoglobulin G; Immunohistochemistry; Kidney; Kidney Diseases, Cystic; Kidney Neoplasms; Middle Aged; Nephritis, Interstitial; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Standardized uptake values highly correlate with tumor size and Fuhrman grade in patients with clear cell renal cell carcinoma.
Topics: Adult; Aged; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kidney Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2014 |
Clinically significant association between the maximum standardized uptake value on 18F-FDG PET and expression of phosphorylated Akt and S6 kinase for prediction of the biological characteristics of renal cell cancer.
Topics: Adult; Aged; Aged, 80 and over; Blotting, Western; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Kidney Neoplasms; Male; Middle Aged; Phosphorylation; Positron-Emission Tomography; Proto-Oncogene Proteins c-akt; Radiopharmaceuticals; Ribosomal Protein S6 Kinases | 2015 |
18-F fluorodeoxyglucose uptake in positron emission tomography as a pathological grade predictor for renal clear cell carcinomas.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Diagnostic role of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography in restaging renal cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2016 |
Preoperative evaluation of renal cell carcinoma by using 18F-FDG PET/CT.
Topics: Adenoma, Oxyphilic; Adult; Aged; Aged, 80 and over; Angiomyolipoma; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Prospective study evaluating the relative sensitivity of 18F-NaF PET/CT for detecting skeletal metastases from renal cell carcinoma in comparison to multidetector CT and 99mTc-MDP bone scintigraphy, using an adaptive trial design.
Topics: Aged; Bone Neoplasms; Carcinoma, Papillary; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kidney Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radionuclide Imaging; Research Design; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2015 |
Metastatic Renal Cell Cancer Treated With Antiangiogenic Therapy Monitoring by 18F-FDG PET/CT.
Topics: Adult; Angiogenesis Inhibitors; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Recurrent renal cell carcinoma: clinical and prognostic value of FDG PET/CT.
Topics: Aged; Carcinoma, Renal Cell; Decision Making; Decision Support Systems, Clinical; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Kidney Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2016 |
[A case report of suspected Stauffer syndrome presenting with fever, extensive inflammation, and abnormal liver function tests].
Topics: Biopsy; Carcinoma, Renal Cell; Fatal Outcome; Fever; Fluorodeoxyglucose F18; Humans; Inflammation; Kidney Neoplasms; Liver Diseases; Liver Function Tests; Male; Middle Aged; Positron-Emission Tomography | 2015 |
Detection of 18F-FDG PET/CT Occult Lesions With 18F-DCFPyL PET/CT in a Patient With Metastatic Renal Cell Carcinoma.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Lysine; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Urea | 2016 |
Clinical role of early dynamic FDG-PET/CT for the evaluation of renal cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2016 |
Renal Cell Carcinoma Arising From Renal Allograft Detected by 18F-FDG PET-CT.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Kidney Transplantation; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
PET/CT imaging of renal cell carcinoma with (18)F-VM4-037: a phase II pilot study.
Topics: Aged; Biomarkers, Tumor; Carbonic Anhydrases; Carcinoma, Renal Cell; Contrast Media; Diagnosis, Differential; Dipeptides; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Multimodal Imaging; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sulfonamides; Tomography, X-Ray Computed | 2016 |
FDG PET/CT as a prognostic biomarker in the era of molecular-targeting therapies: max SUVmax predicts survival of patients with advanced renal cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Molecular Targeted Therapy; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Nephrectomy; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed; Treatment Outcome | 2016 |
Comparison of 11C-4DST and 18F-FDG PET/CT imaging for advanced renal cell carcinoma: preliminary study.
Topics: Aged; Carbon Radioisotopes; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thymidine | 2016 |
Complimentary Pattern of Uptake in 18F-FDG PET/CT and 68Ga-Prostate-Specific Membrane Antigen PET/CT in a Case of Metastatic Clear Cell Renal Carcinoma.
Topics: Aged, 80 and over; Carcinoma, Renal Cell; Edetic Acid; Female; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Kidney Neoplasms; Neoplasm Metastasis; Oligopeptides; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2016 |
Enhanced MRI and 18F-FDG PET/CT Findings of Preoperative Primary Renal Collecting Duct Carcinoma.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymph Nodes; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retroperitoneal Neoplasms | 2016 |
Cholinergic PET imaging in infections and inflammation using
Topics: Acetylcholinesterase; Adult; Aged; Animals; Carbon Radioisotopes; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cholinesterase Inhibitors; Donepezil; Female; Fluorodeoxyglucose F18; Humans; Indans; Kidney Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred C57BL; Middle Aged; Piperidines; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Staphylococcal Infections; Swine; Vesicular Acetylcholine Transport Proteins | 2017 |
Noninvasive determination of renal tumor histology utilizing molecular imaging.
Topics: Antibodies, Monoclonal; Biopsy; Carbonic Anhydrase IX; Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney; Kidney Neoplasms; Molecular Imaging; Positron-Emission Tomography; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2016 |
The acceleration of glucose accumulation in renal cell carcinoma assessed by FDG PET/CT demonstrated acquisition of resistance to tyrosine kinase inhibitor therapy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Protein Kinase Inhibitors; Radiopharmaceuticals; Survival Rate | 2017 |
Does F-18 FDG-PET still play a role in metastatic renal cell carcinoma?
Topics: Biomarkers, Tumor; Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Neoplasm Grading; Neoplasm Staging; Patient Selection; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity | 2017 |
Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative 18F-FDG PET/CT in Patients With Renal Cell Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Kidney Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2017 |
Usefulness of 18F-FDG PET Associated With a High-Fat, Low-Carbohydrate Preparation for the Detection of a Myocardial-Embedded Metastasis.
Topics: Aged; Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Kidney Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2017 |
Prognostic Value of Pretreatment Metabolic Tumor Volume and Total Lesion Glycolysis Using 18F-FDG PET/CT in Patients With Metastatic Renal Cell Carcinoma Treated With Anti-Vascular Endothelial Growth Factor-Targeted Agents.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Indazoles; Indoles; Kidney Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Positron Emission Tomography Computed Tomography; Pyrimidines; Pyrroles; Radiopharmaceuticals; Sorafenib; Sulfonamides; Sunitinib | 2017 |
Significance of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for the postoperative surveillance of advanced renal cell carcinoma.
Topics: Adult; Aged; Carcinoma, Renal Cell; Epidemiologic Methods; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Widespread metastases from sarcomatoid renal cell carcinoma detected by (18)F-FDG positron emission tomography/computed tomography.
Topics: Carcinoma, Renal Cell; Disease Progression; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole Body Imaging | 2009 |
Giant cell arteritis on 18F-FDG PET/CT.
Topics: Aortitis; Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Incidental Findings; Kidney Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2009 |
Bellini duct carcinoma: visualization on F-18 FDG PET/CT.
Topics: Adult; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
A rare presentation of metastatic renal clear cell carcinoma to the tongue seen on FDG PET.
Topics: Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kidney Neoplasms; Middle Aged; Positron-Emission Tomography; Tongue Neoplasms | 2009 |
Delayed diuretic FDG PET/CT scan facilitates detection of renal urothelial cell carcinoma.
Topics: Carcinoma, Renal Cell; Diuretics; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Urothelium | 2009 |
The potential clinical value of FDG-PET for recurrent renal cell carcinoma.
Topics: Aged; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate | 2011 |
An unusual case of synchronous renal cell carcinoma in a horseshoe kidney and intrahepatic cholangiocarcinoma.
Topics: Aged; Bile Duct Neoplasms; Carcinoma, Renal Cell; Cholangiocarcinoma; Fluorodeoxyglucose F18; Humans; Kidney; Kidney Neoplasms; Male; Radionuclide Imaging; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2009 |
Incidental detection of renal transplantation urinary leakage on FDG-PET/CT imaging for evaluation of lung metastases.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Kidney Transplantation; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Urination Disorders | 2009 |
Isolated gastric metastasis from renal cell carcinoma 19 years after radical nephrectomy.
Topics: Aged; Biopsy; Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Gastrectomy; Gastroscopy; Humans; Kidney Neoplasms; Male; Nephrectomy; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Time Factors; Treatment Outcome | 2010 |
Isolated facial muscle metastasis from renal cell carcinoma on F-18 FDG PET/CT.
Topics: Aged; Carcinoma, Renal Cell; Facial Neoplasms; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Muscle Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2010 |
18F-FDG PET/CT evaluation of lymphoma with renal involvement: comparison with renal carcinoma.
Topics: Adolescent; Adult; Aged; Carcinoma, Renal Cell; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Young Adult | 2010 |
Significance of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for the postoperative surveillance of advanced renal cell carcinoma.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
Role of FDG PET-CT in recurrent renal cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Nephrectomy; Positron-Emission Tomography; Recurrence; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2010 |
Imaging of acquired cystic disease-associated renal cell carcinoma by contrast-enhanced ultrasonography with perflubutane microbubbles and positron emission tomography-computed tomography.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Diseases, Cystic; Kidney Neoplasms; Male; Microbubbles; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Renal Dialysis; Tomography, X-Ray Computed; Ultrasonography | 2011 |
Renal cell carcinoma presenting as isolated thyroid metastasis 13 years after radical nephrectomy, detected on F-18 FDG PET/CT.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Nephrectomy; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed | 2010 |
Azygos venous tumor thrombus from renal cell carcinoma detected by F-18 FDG PET/CT.
Topics: Aged, 80 and over; Azygos Vein; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Renal Veins; Tomography, X-Ray Computed; Vascular Neoplasms; Venous Thrombosis | 2010 |
Impact of maximum standardized uptake value (SUVmax) evaluated by 18-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (18F-FDG-PET/CT) on survival for patients with advanced renal cell carcinoma: a preliminary report.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Japan; Kaplan-Meier Estimate; Kidney Neoplasms; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Time Factors; Tomography, X-Ray Computed | 2010 |
Combined positron emission tomography/computed tomography in sunitinib therapy assessment of patients with metastatic renal cell carcinoma.
Topics: Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Indoles; Kidney Neoplasms; Middle Aged; Positron-Emission Tomography; Protein Kinase Inhibitors; Pyrroles; Sunitinib; Tomography, X-Ray Computed | 2011 |
Thyroid metastasis from primary renal cell cancer on FDG PET/CT.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed | 2011 |
Tumor-to-tumor metastasis: report of a case of renal cell carcinoma metastasizing to a pancreatic endocrine neoplasm.
Topics: Carcinoma, Renal Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Pancreatectomy; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Splenectomy; Tomography, X-Ray Computed | 2011 |
A prospective diagnostic accuracy study of F-18 fluorodeoxyglucose-positron emission tomography/computed tomography in the evaluation of indeterminate renal masses.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; Carcinoma, Renal Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2011 |
Long-term survival in a patient with node-positive adult-onset Xp11.2 translocation renal cell carcinoma.
Topics: Adult; Carcinoma, Renal Cell; Chromosome Aberrations; Chromosomes, Human, X; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymph Nodes; Nephrectomy; Radiopharmaceuticals; Recurrence; Translocation, Genetic; Treatment Outcome | 2011 |
Searching for alternatives to full kinetic analysis in 18F-FDG PET: an extension of the simplified kinetic analysis method.
Topics: Algorithms; Area Under Curve; Artificial Intelligence; Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Infusions, Intravenous; Kidney Neoplasms; Kinetics; Lymphatic Metastasis; Magnetic Resonance Imaging; Models, Statistical; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2011 |
FDG PET/CT in detection of adrenal metastasis in patients with renal cell carcinoma.
Topics: Adrenal Gland Neoplasms; Aged; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Immunotherapy response evaluation with (18)F-FDG-PET in patients with advanced stage renal cell carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Immunotherapy; Interferon-alpha; Interleukin-2; Kidney Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Better late than early: FDG-PET imaging in metastatic renal cell carcinoma.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
Acute visual loss after preoperative embolization of an ethmoidal metastasis.
Topics: Acute Disease; Adult; Blindness; Carcinoma, Renal Cell; Embolization, Therapeutic; Ethmoid Sinus; Fluorescein Angiography; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Nephrectomy; Ophthalmic Artery; Paranasal Sinus Neoplasms; Positron-Emission Tomography; Visual Acuity | 2012 |
Co-existing sarcoidosis confounds the staging of bilateral renal cell carcinoma.
Topics: Carcinoma, Renal Cell; Diverticulitis; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Middle Aged; Neoplasm Staging; Nephrectomy; Radiopharmaceuticals; Sarcoidosis, Pulmonary; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2011 |
Early assessment by FDG-PET/CT of patients with advanced renal cell carcinoma treated with tyrosine kinase inhibitors is predictive of disease course.
Topics: Adult; Aged; Aged, 80 and over; Benzenesulfonates; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Indoles; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Niacinamide; Phenylurea Compounds; Positron-Emission Tomography; Prognosis; Protein Kinase Inhibitors; Pyridines; Pyrroles; Sorafenib; Sunitinib; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Left ventricular myocardium metastasis in a patient with primary renal cell carcinoma detected by 18F-FDG PET/CT.
Topics: Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Heart Neoplasms; Heart Ventricles; Humans; Kidney Neoplasms; Middle Aged; Multimodal Imaging; Myocardium; Positron-Emission Tomography; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
Skeletal metastases from renal cell carcinoma: diagnostic uncertainty with molecular imaging.
Topics: Bone Neoplasms; Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Middle Aged; Molecular Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Medronate | 2012 |
18F-FDG PET/CT in a patient affected by renal collecting duct (Bellini) carcinoma.
Topics: Adult; Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymphatic Metastasis; Male; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Chronic myeloid leukemia detected on FDG PET/CT imaging in a patient with renal cell carcinoma.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Metastatic lung nodule diagnosed on 18F-FDG PET/CT-guided fine needle aspiration in a patient with renal cell carcinoma.
Topics: Biopsy, Fine-Needle; Carcinoma, Renal Cell; Contrast Media; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lung; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diphosphate bone scan to detect bone metastases in patients with renal cell carcinomas - a preliminary report.
Topics: Aged; Bone Neoplasms; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Technetium Tc 99m Medronate; Tomography, Emission-Computed | 2002 |
Re: Clinical role of f-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Neoplasm Recurrence, Local; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
[Renal cell carcinoma metastasis in a microfollicular adenoma of the thyroid gland].
Topics: Adenoma; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Middle Aged; Nephrectomy; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Neoplasms | 2002 |
Comparison of SUV and Patlak slope for monitoring of cancer therapy using serial PET scans.
Topics: Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Interleukin-2; Kidney Neoplasms; Male; Radiopharmaceuticals; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2003 |
Differentiating solitary pulmonary metastases in patients with renal cell carcinomas by 18F-fluoro-2-deoxyglucose positron emission tomography--a preliminary report.
Topics: Adult; Aged; Carcinoma, Renal Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 2003 |
F-18 fluorodeoxyglucose positron emission tomography in the evaluation of distant metastases from renal cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Diagnostic role of [F-18]-FDG positron emission tomography in restaging renal cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma.
Topics: Adult; Aged; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 2004 |
PET radioimmunoscintigraphy of renal cell cancer using 89Zr-labeled cG250 monoclonal antibody in nude rats.
Topics: Animals; Antibodies, Monoclonal; Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Indium Radioisotopes; Isotope Labeling; Kidney Neoplasms; Positron-Emission Tomography; Radioimmunodetection; Rats; Rats, Nude; Recombinant Fusion Proteins; Xenograft Model Antitumor Assays; Zirconium | 2004 |
Large renal cell carcinoma isometabolic with normal liver on F-18 FDG PET scan.
Topics: Carcinoma, Renal Cell; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Liver; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
Positron emission tomography imaging of renal vein and inferior vena cava tumor thrombus from renal cell carcinoma.
Topics: Aged; Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Neoplasm Invasiveness; Positron-Emission Tomography; Radiopharmaceuticals; Renal Veins; Vena Cava, Inferior; Venous Thrombosis | 2005 |
The detection of renal cell carcinoma with adrenal and para-aortic lymph node metastases by FDG-PET.
Topics: Adrenal Gland Neoplasms; Aorta; Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
[Positron emission tomography in oncourology].
Topics: Adolescent; Adult; Aged; Carcinoma, Embryonal; Carcinoma, Renal Cell; Choriocarcinoma; Data Interpretation, Statistical; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Kidney; Kidney Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms; Radiopharmaceuticals; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Testis | 2005 |
Calyceal diverticulum mimicking a renal tumor on FDG PET imaging.
Topics: Aged; Carcinoma, Renal Cell; Diagnosis, Differential; Diverticulum; Extravasation of Diagnostic and Therapeutic Materials; Fluorodeoxyglucose F18; Humans; Kidney Diseases, Cystic; Kidney Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
Usefulness of 18-fluorodeoxyglucose positron emission tomography in the evaluation of tumor cardiac thrombus from renal cell carcinoma.
Topics: Carcinoma, Renal Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Kidney Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Vena Cava, Inferior; Venous Thrombosis | 2006 |
The ischiopubic synchondrosis: changing appearance on PET/CT as a mimic of disease.
Topics: Bone Neoplasms; Carcinoma, Renal Cell; Cartilage; Child; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Nephrectomy; Osteogenesis; Osteolysis; Positron-Emission Tomography; Pubic Symphysis; Pubic Symphysis Diastasis; Radiopharmaceuticals; Time Factors; Tomography, X-Ray Computed | 2006 |
CT with anatomic delineation identifying renal cell carcinoma with normal metabolic activity on F-18 FDG PET imaging.
Topics: Adult; Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Aged; Carcinoid Tumor; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Diagnosis, Differential; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Frozen Sections; Humans; Lung Diseases; Lung Diseases, Fungal; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Solitary Pulmonary Nodule; Thoracic Surgery, Video-Assisted; Tomography, X-Ray Computed | 2006 |
Sarcomatoid renal cell carcinoma: rapid dissemination detected on FDG PET-CT.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Tomography, X-Ray Computed | 2006 |
PET scans for decision-making in metastatic renal cell carcinoma: a single-institution evaluation.
Topics: Adult; Aged; Carcinoma, Renal Cell; Decision Making; Female; Fluorodeoxyglucose F18; Humans; Immunotherapy; Kidney Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity | 2006 |
[Malignant tumor with false negative 18F-FDG PET image].
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Carcinoma, Signet Ring Cell; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Liver Neoplasms; Male; Middle Aged; Omentum; Peritoneal Neoplasms; Positron-Emission Tomography; Radiographic Image Enhancement; Stomach Neoplasms; Tomography, X-Ray Computed | 2006 |
FDG uptake in inferior vena cava tumor thrombus from renal cell carcinoma on positron emission tomography.
Topics: Aged; Budd-Chiari Syndrome; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Vena Cava, Inferior | 2007 |
F-18 FDG PET in Ormond disease in a patient with renal cell carcinoma.
Topics: Adult; Carcinoma, Renal Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Incidental Findings; Kidney Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Retroperitoneal Fibrosis | 2007 |
Usefulness of F-18 FDG-PET in a long-term hemodialysis patient with renal cell carcinoma and pheochromocytoma.
Topics: Carcinoma, Renal Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Kidney; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Renal Dialysis; Tomography, X-Ray Computed | 2007 |
F-18 FDG PET findings in a port site recurrence after laparoscopic radical nephrectomy in a patient with renal cell carcinoma.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Laparoscopy; Male; Middle Aged; Neoplasm Recurrence, Local; Nephrectomy; Radiopharmaceuticals; Tomography, Emission-Computed | 2008 |
Primary synovial sarcoma of the kidney: use of PET/CT in diagnosis and follow-up.
Topics: Carcinoma, Renal Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma, Synovial; Tomography, X-Ray Computed | 2008 |
[Positron emission tomography. Introduction of a new procedure in diagnosis of urologic tumors and initial clinical results].
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Carcinoma, Renal Cell; Combined Modality Therapy; Deoxyglucose; Equipment Design; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Postoperative Complications; Salvage Therapy; Seminoma; Testicular Neoplasms; Tomography, Emission-Computed; Urinary Bladder Neoplasms; Urogenital Neoplasms | 1995 |
[Positron emission tomography in diagnosis of renal cell carcinoma].
Topics: Blood Glucose; Carcinoma, Renal Cell; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Tomography, Emission-Computed | 1996 |
Identification of interleukin-2-induced complete response in metastatic renal cell carcinoma by FDG PET despite radiographic evidence suggesting persistent tumor.
Topics: Carcinoma, Renal Cell; Deoxyglucose; Diagnostic Errors; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Interleukin-2; Kidney Neoplasms; Middle Aged; Neoplasm, Residual; Pelvic Neoplasms; Radiography; Radiopharmaceuticals; Tomography, Emission-Computed | 1997 |
Evaluation of FDG uptake by renal malignancies (primary tumor or metastases) using a coincidence detection gamma camera.
Topics: Carcinoma, Renal Cell; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Nephrectomy; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
Standardized uptake value as an unreliable index of renal disease on fluorodeoxyglucose PET imaging.
Topics: Aged; Blood Glucose; Carcinoma, Renal Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Kidney; Kidney Diseases, Cystic; Kidney Neoplasms; Lung; Lung Neoplasms; Male; Predictive Value of Tests; Tomography, Emission-Computed | 2000 |
Uptake of cis-4-[18F]fluoro-L-proline in urologic tumors.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Penile Neoplasms; Pilot Projects; Proline; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma.
Topics: Adult; Aged; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Tomography, Emission-Computed | 2001 |
Intramedullary spinal cord metastasis from renal cell carcinoma: detection by positron emission tomography.
Topics: Adenocarcinoma, Clear Cell; Adult; Carcinoma, Renal Cell; Combined Modality Therapy; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Radionuclide Imaging; Radiopharmaceuticals; Spinal Cord Neoplasms; Tomography, X-Ray Computed; Whole-Body Counting | 2001 |
The usefulness of F-18 deoxyglucose whole-body positron emission tomography (PET) for re-staging of renal cell cancer.
Topics: Adult; Aged; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Early changes in tumor metabolism after treatment: the effects of stereotactic radiotherapy.
Topics: Brain Neoplasms; Carcinoma, Renal Cell; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Kidney Neoplasms; Melanoma; Stereotaxic Techniques; Tomography, Emission-Computed | 1991 |
[Validity of positron emission tomography (PET) using 2-deoxy-2-[18F]fluoro-D-glucose (FDG) in patients with renal cell carcinoma (preliminary report)].
Topics: Adult; Aged; Carcinoma, Renal Cell; Deoxy Sugars; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Predictive Value of Tests; Tomography, Emission-Computed | 1988 |